Cancer

24 November 2009

Sleep Disorders Plague Cancer Patients

More than three-quarters getting chemo deal with insomnia, study shows

0

This article has not necessarily been edited by Health24.

MONDAY, Nov. 23 (HealthDay News) -- Insomnia and sleep disorders affect more than three-quarters of cancer patients undergoing chemotherapy, a rate nearly three times higher than that of the general population, a new study finds.

The problem is more common in younger patients and in those with lung and breast cancers, said University of Rochester Medical Center researchers, who assessed sleep problems in 823 cancer patients.

Questionnaires completed by patients after their first two chemotherapy treatments revealed that 37 percent suffered from insomnia symptoms and another 43 percent had insomnia syndrome, which means they had difficulty falling asleep and staying asleep at least three nights per week, the researchers reported in the Nov. 23 online edition of the Journal of Clinical Oncology.

"These numbers are very high, and something we can't ignore," study author Oxana Palesh, a research assistant professor of radiation oncology, said in a news release from the medical center. "The good news is that insomnia is a very treatable problem that can be addressed quickly so it doesn't compound other symptoms."

Sleep problems -- which are generally combined with fatigue and depression -- haven't typically been studied to determine their causes and impact on patients' quality of life, she noted.

More information

The U.S. National Cancer Institute has more about cancer and sleep problems.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst and Head of Advocacy Magdalene Seguin. For more information, visit cansa.org.za.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules